Stock Events

Stock Events

Synlogic 

$1.2150
16
+$0.02+1.25% 17:09 Today

Statistics

Day High
1.2
Day Low
1.2
52W High
1.87
52W Low
0.54
Volume
10
Avg. Volume
73,217
Mkt Cap
14.21M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

11NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Next
Next
-0.15
-0.13
-0.12
-0.1
Expected EPS
N/A
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
0Revenue
-1.01MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow SYBX. It's not an investment recommendation.
Apple
4
AAPL
Johnson & Johnson
4
JNJ
Palantir Technologies
4
PLTR
SoFi Technologies
4
SOFI

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Sarepta Therapeutics
SRPT
Mkt Cap1.91B
Sarepta Therapeutics focuses on the discovery and development of RNA-based therapeutics, competing in the genetic medicine space similar to Synlogic's approach to synthetic biotics.
CRISPR Therapeutics
CRSP
Mkt Cap5.18B
CRISPR Therapeutics is involved in gene editing, a direct competitor in the field of genetic and cellular therapies where Synlogic operates.
Editas Medicine
EDIT
Mkt Cap433.1M
Editas Medicine works on gene editing using CRISPR technology, directly competing with Synlogic in the development of novel genetic treatments.
Intellia Therapeutics
NTLA
Mkt Cap1.67B
Intellia Therapeutics is another key player in the CRISPR/Cas9 gene editing space, making it a competitor in the genetic therapy market.
Beam Therapeutics
BEAM
Mkt Cap2.76B
Beam Therapeutics focuses on precision genetic medicines using base editing, a next-generation CRISPR technology, competing in the same innovative healthcare sector.
Regenxbio
RGNX
Mkt Cap710.63M
REGENXBIO is a leader in the development of AAV-based gene therapies, which places it in competition with companies developing other advanced genetic therapies.
Fate Therapeutics
FATE
Mkt Cap307.94M
Fate Therapeutics is focused on the development of programmed cellular immunotherapies for cancer and immune disorders, competing in the cell therapy space alongside Synlogic's synthetic biotics approach.

About

Synlogic, Inc. does not have significant operations. It was previously engaged in the discovery and development of synthetic biotics to treat metabolic diseases. Synlogic, Inc. is based in Winchester, Massachusetts.
Show more...
CEO
Mary Beth Dooley
Employees
1
Country
United States
ISIN
US87166L2097
WKN
000A3EWCN

Listings

STU
DE
MIN.STU
LSE
GB
0A8U.LSE
MU
DE
MIN.MU
OTC Link
US
SYBX

0 Comments

Share your thoughts

FAQ

What is Synlogic stock price today?▼
The current price of SYBX is $1.22 USD — it has increased by +1.25% in the past 24 hours. Watch Synlogic stock price performance more closely on the chart.
What is Synlogic stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Synlogic stocks are traded under the ticker SYBX.
Is Synlogic stock price growing?▼
SYBX stock has risen by +2.97% compared to the previous week, the month change is a +62.02% rise, over the last year Synlogic has showed a -15.03% decrease.
What is Synlogic market cap?▼
Today Synlogic has the market capitalization of 14.21M
When is the next Synlogic earnings date?▼
Synlogic is going to release the next earnings report on November 11, 2026.
What is Synlogic revenue for the last year?▼
Synlogic revenue for the last year amounts to 0 USD.
What is Synlogic net income for the last year?▼
SYBX net income for the last year is -1.01M USD.
How many employees does Synlogic have?▼
As of August 18, 2026, the company has 1 employees.
In which sector is Synlogic located?▼
Synlogic operates in the Health & Wellness sector.
When did Synlogic complete a stock split?▼
The last stock split for Synlogic was on September 28, 2023 with a ratio of 1:15.
Where is Synlogic headquartered?▼
Synlogic is headquartered in Winchester, United States.